Literature DB >> 1738795

Low doses of oxytocin facilitate social recognition in rats.

P Popik1, J Vetulani, J M van Ree.   

Abstract

Social recognition of juveniles by adult male residents has been shown to be modulated by neurohypophyseal hormones. The decrease of social investigation behavior during a second encounter with the same juvenile serves as index for social recognition. In the present study it was found that low doses (0.09-6.0 ng.kg-1) of oxytocin (OXT) given subcutaneously dose dependently facilitated social recognition. The effect of OXT appeared specific, since no change in social investigation was found when a novel juvenile was tested during the second encounter. No disturbances of social recognition by the low doses of OXT could be detected, in contrast to higher doses of this hormone. Other neurohypophyseal hormones, vasopressin and vasotocin, did not facilitate social recognition when tested in the same range of low doses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738795     DOI: 10.1007/bf02253591

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Opposite action of oxytocin and its peptide antagonists on social memory in rats.

Authors:  P Popik; J Vetulani
Journal:  Neuropeptides       Date:  1991-01       Impact factor: 3.286

2.  Blood levels of oxytocin in the female goat during coitus and in response to stimuli associated with mating.

Authors:  A S McNeilly; H A Ducker
Journal:  J Endocrinol       Date:  1972-09       Impact factor: 4.286

3.  Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.

Authors:  D de Wied; O Gaffori; J P Burbach; G L Kovács; J M van Ree
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

4.  Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress.

Authors:  D M Gibbs
Journal:  Life Sci       Date:  1984-07-30       Impact factor: 5.037

Review 5.  Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects.

Authors:  D De Wied; J Jolles
Journal:  Physiol Rev       Date:  1982-07       Impact factor: 37.312

6.  Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF.

Authors:  W B Mens; A Witter; T B van Wimersma Greidanus
Journal:  Brain Res       Date:  1983-02-28       Impact factor: 3.252

7.  Opposite effects of oxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat.

Authors:  B Bohus; I Urban; T B van Wimersma Greidanus; D de Wied
Journal:  Neuropharmacology       Date:  1978 Apr-May       Impact factor: 5.250

8.  Centrally injected arginine vasopressin (AVP) facilitates social memory in rats.

Authors:  M Le Moal; R Dantzer; B Michaud; G F Koob
Journal:  Neurosci Lett       Date:  1987-06-26       Impact factor: 3.046

9.  Increase in oxytocin secretion at ejaculation in male.

Authors:  S Ogawa; S Kudo; Y Kitsunai; S Fukuchi
Journal:  Clin Endocrinol (Oxf)       Date:  1980-07       Impact factor: 3.478

10.  Release of oxytocin during suckling and parturition in the rat.

Authors:  T Higuchi; K Honda; T Fukuoka; H Negoro; K Wakabayashi
Journal:  J Endocrinol       Date:  1985-06       Impact factor: 4.286

View more
  38 in total

Review 1.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

Review 2.  Neural mechanisms of reproduction in females as a predisposing factor for drug addiction.

Authors:  Valerie L Hedges; Nancy A Staffend; Robert L Meisel
Journal:  Front Neuroendocrinol       Date:  2010-02-19       Impact factor: 8.606

3.  Evidence for a role of oxytocin receptors in the long-term establishment of dominance hierarchies.

Authors:  Marjan Timmer; M Isabel Cordero; Yannick Sevelinges; Carmen Sandi
Journal:  Neuropsychopharmacology       Date:  2011-07-13       Impact factor: 7.853

Review 4.  Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives.

Authors:  Martien J Kas; Jeffrey C Glennon; Jan Buitelaar; Elodie Ey; Barbara Biemans; Jacqueline Crawley; Robert H Ring; Clara Lajonchere; Frederic Esclassan; John Talpos; Lucas P J J Noldus; J Peter H Burbach; Thomas Steckler
Journal:  Psychopharmacology (Berl)       Date:  2013-09-19       Impact factor: 4.530

5.  First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma.

Authors:  Anika Hoffmann; Jale Özyurt; Kristin Lohle; Julia Reichel; Christiane M Thiel; Hermann L Müller
Journal:  Endocrine       Date:  2017-02-17       Impact factor: 3.633

Review 6.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

7.  Role of oxytocin receptors in modulation of fear by social memory.

Authors:  Yomayra F Guzmán; Natalie C Tronson; Keisuke Sato; Ivana Mesic; Anita L Guedea; Katsuhiko Nishimori; Jelena Radulovic
Journal:  Psychopharmacology (Berl)       Date:  2013-11-28       Impact factor: 4.530

8.  WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.

Authors:  Callum Hicks; Linnet Ramos; Tristan A Reekie; Rajeshwar Narlawar; Michael Kassiou; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

9.  A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.

Authors:  Cristina Cacciotti-Saija; Robyn Langdon; Philip B Ward; Ian B Hickie; Elizabeth M Scott; Sharon L Naismith; Loretta Moore; Gail A Alvares; Marie Antoinette Redoblado Hodge; Adam J Guastella
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

Review 10.  Cognitive-enhancing effects of angiotensin IV.

Authors:  Paul R Gard
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.